New studies show that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic polypeptide receptor agonists (GIP-RA) cause almost as much weight loss as gastric surgery ...

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) commonly coexists with poor muscle health, which encompasses three interconnected domains: muscle mass, muscle function, and muscle ...

Weight-loss drugs like semaglutide may melt fat, but at the cost of muscle mass. A new review reveals how to protect your strength while reaping the benefits. Study: Glucagon-like peptide-1 receptor ...

Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the ...

Although strength training exercises have been shown to limit muscle mass loss that accompanies significant weight loss, ...

Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs taken to treat obesity. Iuliia Burmistrova/Getty Images GLP-1 drugs have helped people successfully achieve and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NATIONAL HARBOR, Md. — GLP-1 receptor agonists are ...

What if GLP-1s aren’t causing muscle loss at all? New data reveals a massive misinterpretation that could change the entire ...